| Quantity | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg | 5 mg, 10 mg, 25 mg, 50 mg | 100 mg, 500 mg, 1 g, 5 g, 10 g | 100 mg, 250 mg, 500 mg, 1 g, 5 g, 10 g, 25 g | 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg |
| Description | T7 peptide (Tumstatin (74-98), human) TFA is an endothelial cell-specific inhibitor. T7 peptide TFA interacts with αVβ3 integrin to inhibit the FAK, PI3-kinase, PKB/Akt, and mTOR signaling pathways in endothelial cells, ultimately suppressing protein synthesis and inducing apoptosis[1] | Enfuvirtide (T20; DP178) acetate is an anti-HIV-1 fusion inhibitor peptide | Papain is a cysteine protease of the peptidase C1 family, which is used in food, pharmaceutical, textile, and cosmetic industries | Pepsin is the major pig and human gastric proteases, it is a pepsin-like minor gastric proteolytic enzymes. Pepsin contributes to proteolysis of food proteins in the vertebrate stomach[1][2] | Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide has robust anti-Survodutide (BI 456906) is a potent, selective glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) dual agonist with EC50s of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. Survodutide, a 29-amino-acid peptide, is a potent acylated peptide containing a C18 fatty acid. Survodutide has robust anti-obesity efficacy achieved by increasing energy expenditure and decreasing food intake[1]... Read More |